Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.
about
Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Development of a 4-aminopyrazo ...... r agent with minimal toxicity.
@en
Development of a 4-aminopyrazo ...... r agent with minimal toxicity.
@nl
type
label
Development of a 4-aminopyrazo ...... r agent with minimal toxicity.
@en
Development of a 4-aminopyrazo ...... r agent with minimal toxicity.
@nl
prefLabel
Development of a 4-aminopyrazo ...... r agent with minimal toxicity.
@en
Development of a 4-aminopyrazo ...... r agent with minimal toxicity.
@nl
P2093
P2860
P1433
P1476
Development of a 4-aminopyrazo ...... r agent with minimal toxicity.
@en
P2093
Byungjin Kim
Byungyeob Baek
Ho Jin Lee
Ho-Young Lee
Hye-Young Min
Jeeyeon Lee
Phuong Chi Pham
Seung Yeob Hyun
P2860
P2888
P356
10.1186/S12943-018-0802-4
P577
2018-02-19T00:00:00Z
P6179
1101066803